-+ 0.00%
-+ 0.00%
-+ 0.00%

Roivant President and Immunovant CEO Eric Venker reports sale of $7.02 million in Roivant common shares

PUBT·10/22/2026 22:45:04
Listen to the news
Roivant President and Immunovant CEO Eric Venker reports sale of $7.02 million in Roivant common shares
  • Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on Oct. 20, 2026.
  • Sales comprised 185,856 shares at $35.09 and 14,144 shares at $35.42.
  • His direct holdings fell to 1,399,154 common shares, as reported in the Form 4 dated Oct. 22, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001635088-26-000116), on October 22, 2026, and is solely responsible for the information contained therein.